Notice of Annual General Meeting

Paris, France and Camberley, UK – 13 May 2022 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual General Meeting (“AGM”) will be held at 2pm CEST/1pm BST on 21 June 2022 as an open virtual meeting. Further details of the AGM will be provided

Visit Page

Full year 2021 results and update on growth strategy

Full year revenue and EBITDA in line with market expectations despite challenging and changing COVID-19 testing marketLeveraging core capabilities to become a leading, global clinical diagnostics company targeting annual revenues in excess of £100m in five years http://novacyt.com/wp-content/uploads/2022/04/Novacyt-Full-year-2021-results-and-update-on-growth-strategy.pdf

Visit Page

DHSC dispute update

Paris, France and Camberley, UK – 26 April 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its ongoing dispute with the Department of Health and Social Care (“DHSC”). http://novacyt.com/wp-content/uploads/2022/04/Novacyt-DHSC-dispute-update-1.pdf

Visit Page